News & AnalysisSwiss biotech firm T3 Pharmaceuticals lands fundingT3 Pharmaceuticals AG, a Swiss biotech company, has raised over 25 million CHF.ByIris Dorbian22 July 2020•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs